Company Information

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE1780.65-14.35 (-0.8 %)
PREV CLOSE ( ) 1795.00
OPEN PRICE ( ) 1752.05
BID PRICE (QTY) 1777.40 (6)
OFFER PRICE (QTY) 1780.65 (1)
VOLUME 783
TODAY'S LOW / HIGH ( )1752.05 1788.20
52 WK LOW / HIGH ( )914.65 1935
NSE1775.40-22.4 (-1.25 %)
PREV CLOSE( ) 1797.80
OPEN PRICE ( ) 1795.00
BID PRICE (QTY) 1775.35 (45)
OFFER PRICE (QTY) 1776.95 (6)
VOLUME 17025
TODAY'S LOW / HIGH( ) 1770.35 1795.00
52 WK LOW / HIGH ( )875 1940
Company SecretarySandeep Phadnis
Non Executive DirectorGaurav Trehan
Prashant Kumar
Additional DirectorAkshay Tanna
Non Executive Independent DirectorPadmini Khare Kaicker
Sumit Bose
Whole Time DirectorNikhil Chopra
Incorporation Year : 18-12 1976

Registered Office :

Address : Neelam Centre, ' B 'wing,4th Floor ,Hind Cycle Road, Worli Mumbai,
Maharashtra-400030 .

Phone : 022- 2482 2222

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.